CoChat

Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency

Open access
Gallego-Cortés, A., Sánchez-Gaona, N., Mancebo-Pérez, C., Ruiz-Isant, O., Benítez-Martínez, A., Landolfi, S., Castellví, J., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Mañalich-Barrachina, L., Prado, JG., Martín-Gayo, E., Falcó, V., Genescà, M., Buzon, MJ. · 2025 · Nature Communications

Published version of a preprint

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

Abstract

HIV persists in diverse tissues, with distinct cellular reservoirs presenting a major barrier to a cure and requiring targeted therapeutic strategies to address this heterogeneity. Here, we develop tissue models of HIV latency using human tonsillar, intestinal and cervicovaginal tissues. These models reveal differential HIV infection across CD4+ T-cell subpopulations, with ART partially restoring CD4+ T cells and reducing intact HIV DNA. T follicular helper cells (TFH CD69+ CCR7-) are the primary inducible reservoir in tonsils, while tissue-resident memory cells (TRM CD69+ CD49a+) dominate in the intestine. Identification of markers for inducible reservoirs shows that CD69, CD45RO, and PD-1 are shared across tissues, while CXCR5 in tonsils and CD49a in the intestine act as tissue-specific markers. Furthermore, using different latency reversal agents (LRAs) demonstrates that Histone Deacetylase Inhibitors (HDACis) fail to induce HIV in any tissue, the SMAC mimetic AZD5582 is effective only in a resident-memory CD4+ T-cell subpopulation in the intestine, and IL-15 exhibits the broadest reactivation potential across tissues and CD4+ T-cell subsets. These models provide insights into the inducible reservoir’s composition in different tissues and inform strategies for its elimination. HIV’s persistence in diverse tissue reservoirs poses a challenge to cure efforts, necessitating targeted approaches. Here, the authors develop human tissue models of HIV latency and find that inducible reservoirs differ across tissues and CD4⁺ T-cell subsets, highlighting tissue-specific markers and IL-15 as the most effective latency reversal agent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-025-65288-9

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Tonsillar, intestinal and cervical models of latent HIV infection. a Representation of the experimental workflow for studying productive and latent HIV infection in tonsillar (TO), intestinal (GUT) and cervicovaginal (CVX) tissues. Conditions: uninfected (HIV-), infected (HIV+), ART-treated (ART), and ART-treated LRA-stimulated (ART+LRA). Created with BioRender: Genescà, M. (2025) https://BioRender.com/wd0r7zx. b Productive HIV infection in the tissue models. Graphs display the percentages of p24+ cells in CD4+ T cells from uninfected and infected tonsils (day 5), and intestinal and cervical tissues (day 6). N = 23, 26 and 5 biological replicates for tonsils, intestine and cervix. Means are represented. c Longitudinal monitoring of HIV infection in tonsillar and intestinal tissue models. Graphs show the percentage of p24+ cells in CD4+ T cells under uninfected, infected and infected ART-treated conditions over 8-9 days. N = 6 biological replicates per tissue. Means and standard error of the means (SEM) are shown. d Effect of ART on HIV infection in tissue models. Graphs display the frequencies of p24+ cells in CD4⁺ T cells from HIV-infected tissues with or without ART for 2–3 days. N = 12, 13 and 7 biological replicates for tonsils, intestine and cervix. Means are represented. e Impact of HIV infection and ART on CD4+ T cells. Graphs depict the frequencies of CD4+ T cells under uninfected, infected and infected ART-treated conditions in all tissue models at days 7-9. N = 6, 6 and 4 biological replicates for tonsils, intestine and cervix. Means and SEM are depicted. f Viral reactivation of the inducible reservoir in the tissue models. Graphs show the frequencies of p24+ cells in CD4+ T cells isolated from HIV-infected ART-treated tissue blocks either unstimulated or stimulated with phorbol 12-myristate 13-acetate and ionomycin (PMA+Iono). N = 12, 13 and 11 biological replicates for tonsils, intestine and cervix. Means are represented. Statistical comparisons between conditions were performed using the Wilcoxon test (b, c, d, f) and the Friedman test (c, e), both two-sided. Significance levels are indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 1 Tonsillar, intestinal and cervical models of latent HIV infection. a Representation of the experimental workflow for studying productive and latent HIV infection in tonsillar (TO), intestinal (GUT) and cervicovaginal (CVX) tissues. Conditions: uninfected (HIV-), infected (HIV+), ART-treated (ART), and ART-treated LRA-stimulated (ART+LRA). Created with BioRender: Genescà, M. (2025) https://BioRender.com/wd0r7zx. b Productive HIV infection in the tissue models. Graphs display the percentages of p24+ cells in CD4+ T cells from uninfected and infected tonsils (day 5), and intestinal and cervical tissues (day 6). N = 23, 26 and 5 biological replicates for tonsils, intestine and cervix. Means are represented. c Longitudinal monitoring of HIV infection in tonsillar and intestinal tissue models. Graphs show the percentage of p24+ cells in CD4+ T cells under uninfected, infected and infected ART-treated conditions over 8-9 days. N = 6 biological replicates per tissue. Means and standard error of the means (SEM) are shown. d Effect of ART on HIV infection in tissue models. Graphs display the frequencies of p24+ cells in CD4⁺ T cells from HIV-infected tissues with or without ART for 2–3 days. N = 12, 13 and 7 biological replicates for tonsils, intestine and cervix. Means are represented. e Impact of HIV infection and ART on CD4+ T cells. Graphs depict the frequencies of CD4+ T cells under uninfected, infected and infected ART-treated conditions in all tissue models at days 7-9. N = 6, 6 and 4 biological replicates for tonsils, intestine and cervix. Means and SEM are depicted. f Viral reactivation of the inducible reservoir in the tissue models. Graphs show the frequencies of p24+ cells in CD4+ T cells isolated from HIV-infected ART-treated tissue blocks either unstimulated or stimulated with phorbol 12-myristate 13-acetate and ionomycin (PMA+Iono). N = 12, 13 and 11 biological replicates for tonsils, intestine and cervix. Means are represented. Statistical comparisons between conditions were performed using the Wilcoxon test (b, c, d, f) and the Friedman test (c, e), both two-sided. Significance levels are indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 2 HIV reservoir size in the tissue models. a Violin plots showing the quantification of total HIV DNA in infected CD4+ T cells from tonsils (TO) at day 7, and intestinal (GUT) and cervicovaginal (CVX) tissues at day 8. Medians and quartiles are represented. b Proportion of HIV DNA forms in CD4+ T cells during productive infection. Pie charts depict the percentages of intact, hypermutated, and 5' deleted HIV DNA forms within infected CD4+ T cells from tonsillar (day 7) and intestinal (day 8) tissues. Mean values are shown. c Comparison of the percentages of HIV DNA forms in CD4+ T cells from infected tonsillar (day 7) and intestinal (day 8) tissues. Mean values and standard error of the means (SEM) are represented. d HIV DNA forms in tonsillar and intestinal models and total HIV DNA in cervical tissues during productive infection (HIV+) and after 2 days of ART (ART) (day 7 for tonsils and day 8 for intestinal and cervical tissues). Median percentages of reduction for all HIV DNA forms are indicated. Empty dots represent values below the limit of detection. N = 6 biological replicates each for tonsils and intestine, N = 8 for cervix. Statistical comparisons between conditions were conducted using the Kruskal-Wallis test with Dunn’s post hoc correction (a); the Mann-Whitney test (c); and the Wilcoxon test (d); all two-sided. Significance levels are indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 2 HIV reservoir size in the tissue models. a Violin plots showing the quantification of total HIV DNA in infected CD4+ T cells from tonsils (TO) at day 7, and intestinal (GUT) and cervicovaginal (CVX) tissues at day 8. Medians and quartiles are represented. b Proportion of HIV DNA forms in CD4+ T cells during productive infection. Pie charts depict the percentages of intact, hypermutated, and 5' deleted HIV DNA forms within infected CD4+ T cells from tonsillar (day 7) and intestinal (day 8) tissues. Mean values are shown. c Comparison of the percentages of HIV DNA forms in CD4+ T cells from infected tonsillar (day 7) and intestinal (day 8) tissues. Mean values and standard error of the means (SEM) are represented. d HIV DNA forms in tonsillar and intestinal models and total HIV DNA in cervical tissues during productive infection (HIV+) and after 2 days of ART (ART) (day 7 for tonsils and day 8 for intestinal and cervical tissues). Median percentages of reduction for all HIV DNA forms are indicated. Empty dots represent values below the limit of detection. N = 6 biological replicates each for tonsils and intestine, N = 8 for cervix. Statistical comparisons between conditions were conducted using the Kruskal-Wallis test with Dunn’s post hoc correction (a); the Mann-Whitney test (c); and the Wilcoxon test (d); all two-sided. Significance levels are indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 3 Distinct CD4+ T-cell compartments in the tissue models and differential distribution of HIV infection in tonsillar and intestinal tissues. a Opt-SNE plots displaying the distribution of the identified CD4+ T-cell clusters from uninfected tonsils (TO,T) at day 8, and intestines (GUT,G) and cervix (CVX,C) at day 9. (b) Heatmap illustrating the Mean Fluorescence Intensity (MFI) of the phenotypic markers across the clusters. c Stacked bar charts showing the median percentage of each CD4+ T-cell cluster from the uninfected tissues. Statistical comparisons were performed using two-sided Kruskal-Wallis tests, with Dunn’s post hoc correction, and significance indicated (*p < 0.05; **p < 0.01, ***p < 0.001; ****p < 0.0001). d Pie charts representing pairwise comparisons of cluster proportions between the uninfected tissues. Median percentages are shown. Statistical values derived from the edgeR method (two-sided), with significance levels indicated (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). e Volcano plots showing the differential cluster proportion between the uninfected (HIV-) and infected (HIV+) conditions in tonsillar and intestinal tissues. The edgeR method (two-sided) was employed, with green dots indicating statistically significant differences (p < 0.05). f HIV infection levels in CD4+ T-cell clusters. Graphs illustrating the percentage of p24+ cells within each cluster from tonsillar (day 8) and intestinal (day 9) tissues. Percentages in HIV- were subtracted. Medians and quartiles are represented. Statistical comparisons between infected and uninfected conditions were performed using a two-sided Wilcoxon test. g Pie charts depicting the contribution of each cluster to total HIV-infected CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. Medians are shown, and statistical comparisons between tissues were performed using a two-sided Mann-Whitney test (**p < 0.01; ****p < 0.0001). Smaller pie charts represent the median percentage of each cluster within the total CD4+ T-cell population. N = 9 biological replicates for tonsils and intestine, N = 10 for cervix in A-D. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 3 Distinct CD4+ T-cell compartments in the tissue models and differential distribution of HIV infection in tonsillar and intestinal tissues. a Opt-SNE plots displaying the distribution of the identified CD4+ T-cell clusters from uninfected tonsils (TO,T) at day 8, and intestines (GUT,G) and cervix (CVX,C) at day 9. (b) Heatmap illustrating the Mean Fluorescence Intensity (MFI) of the phenotypic markers across the clusters. c Stacked bar charts showing the median percentage of each CD4+ T-cell cluster from the uninfected tissues. Statistical comparisons were performed using two-sided Kruskal-Wallis tests, with Dunn’s post hoc correction, and significance indicated (*p < 0.05; **p < 0.01, ***p < 0.001; ****p < 0.0001). d Pie charts representing pairwise comparisons of cluster proportions between the uninfected tissues. Median percentages are shown. Statistical values derived from the edgeR method (two-sided), with significance levels indicated (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). e Volcano plots showing the differential cluster proportion between the uninfected (HIV-) and infected (HIV+) conditions in tonsillar and intestinal tissues. The edgeR method (two-sided) was employed, with green dots indicating statistically significant differences (p < 0.05). f HIV infection levels in CD4+ T-cell clusters. Graphs illustrating the percentage of p24+ cells within each cluster from tonsillar (day 8) and intestinal (day 9) tissues. Percentages in HIV- were subtracted. Medians and quartiles are represented. Statistical comparisons between infected and uninfected conditions were performed using a two-sided Wilcoxon test. g Pie charts depicting the contribution of each cluster to total HIV-infected CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. Medians are shown, and statistical comparisons between tissues were performed using a two-sided Mann-Whitney test (**p < 0.01; ****p < 0.0001). Smaller pie charts represent the median percentage of each cluster within the total CD4+ T-cell population. N = 9 biological replicates for tonsils and intestine, N = 10 for cervix in A-D. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 4 Tonsillar and intestinal inducible HIV reservoirs are constituted of distinct subpopulations of CD4+ T cells. a Inducible HIV reservoirs in CD4+ T-cell clusters after viral reactivation with PMA and ionomycin (PMA+Iono). Graphs show the percentage of p24+ cells within each cluster of virally reactivated CD4+ T cells from tonsillar tissues (TO) at day 8 and intestinal tissues (GUT) at day 9. Percentages in the ART-treated condition were subtracted from those in the PMA/ionomycin-stimulated condition. Median values with quartiles are represented. Statistical comparisons between the unstimulated (ART) and PMA/ionomycin-reactivated conditions were conducted using the two-sided Wilcoxon test, with significance indicated numerically. b Pie charts illustrating the contribution of each cluster to the overall inducible reservoir in CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. Medians of these percentages are depicted, and statistical comparisons were performed using the two-sided Mann-Whitney test, with significance levels denoted (*p < 0.05; **p < 0.01 and ***p < 0.001). Smaller pie charts represent the median percentage of each cluster within the CD4+ T-cell population under PMA/ionomycin-stimulated condition. c Pie charts displaying the distribution of clusters derived from Boolean gating of phenotypic markers within the p24+ CD4+ T-cell population. Arcs represent the expression of the phenotypic markers, each depicted in a distinct colour. All p24+ CD4+ T cells express CD69. N = 9 biological replicates each for tonsils and intestine. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 4 Tonsillar and intestinal inducible HIV reservoirs are constituted of distinct subpopulations of CD4+ T cells. a Inducible HIV reservoirs in CD4+ T-cell clusters after viral reactivation with PMA and ionomycin (PMA+Iono). Graphs show the percentage of p24+ cells within each cluster of virally reactivated CD4+ T cells from tonsillar tissues (TO) at day 8 and intestinal tissues (GUT) at day 9. Percentages in the ART-treated condition were subtracted from those in the PMA/ionomycin-stimulated condition. Median values with quartiles are represented. Statistical comparisons between the unstimulated (ART) and PMA/ionomycin-reactivated conditions were conducted using the two-sided Wilcoxon test, with significance indicated numerically. b Pie charts illustrating the contribution of each cluster to the overall inducible reservoir in CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. Medians of these percentages are depicted, and statistical comparisons were performed using the two-sided Mann-Whitney test, with significance levels denoted (*p < 0.05; **p < 0.01 and ***p < 0.001). Smaller pie charts represent the median percentage of each cluster within the CD4+ T-cell population under PMA/ionomycin-stimulated condition. c Pie charts displaying the distribution of clusters derived from Boolean gating of phenotypic markers within the p24+ CD4+ T-cell population. Arcs represent the expression of the phenotypic markers, each depicted in a distinct colour. All p24+ CD4+ T cells express CD69. N = 9 biological replicates each for tonsils and intestine. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 5 Differences in the efficacy of current LRAs in inducing viral reactivation of tissue reservoirs. a Viral reactivation in ART-treated CD4+ T cells from tonsillar (TO), intestinal (GUT) and cervical (CVX) tissues. Graphs display the percentage of p24+ cells within CD4+ T cells in unstimulated (ART) and LRA-stimulated conditions: PMA and ionomycin (PMA+Iono), Ingenol (ING), Romidepsin (RMD), Ingenol and Romidepsin (I+R), Panobinostat (PNB), AZD5582 (AZD) and IL-15. N = 12, 13 and 11 biological replicates for tonsils, intestine and cervix. Percentages in ART were subtracted from those in each LRA-stimulated condition. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted. b Pie charts illustrating the contribution of LRAs to HIV reactivation in tonsillar and intestinal CD4+ T cells. N = 9 and 7 biological replicates for tonsils and intestine. Means are depicted. Statistical comparisons between tissues were performed. c SIMOA measurements of p24 in supernatants from tonsillar and intestinal CD4⁺ T cells HIV-infected (HIV+), ART-treated and ART-treated LRA-stimulated. N = 3 biological replicates per tissue. d Effect of LRAs on ART-treated tonsillar and intestinal CD4+ T-cell subpopulations. Graphs display the percentage of p24+ cells within clusters following stimulation with ING, I+R, AZD or IL-15. Percentages in ART were subtracted. N = 9 biological replicates per tissue. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted. e Pie charts illustrating the contribution of each cluster to total reactivated CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. N = 9 biological replicates per tissue. Median percentages are depicted, and statistical comparisons between tissues were conducted. Smaller pie charts represent the median percentage of each cluster within the LRA-stimulated CD4+ T-cell population. Statistical tests (all two-sided): Wilcoxon test (a, d); Mann-Whitney (b, e). Significance levels are indicated numerically or as *p < 0.05; **p < 0.01; ***p < 0.001. All experiments except (c) were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 5 Differences in the efficacy of current LRAs in inducing viral reactivation of tissue reservoirs. a Viral reactivation in ART-treated CD4+ T cells from tonsillar (TO), intestinal (GUT) and cervical (CVX) tissues. Graphs display the percentage of p24+ cells within CD4+ T cells in unstimulated (ART) and LRA-stimulated conditions: PMA and ionomycin (PMA+Iono), Ingenol (ING), Romidepsin (RMD), Ingenol and Romidepsin (I+R), Panobinostat (PNB), AZD5582 (AZD) and IL-15. N = 12, 13 and 11 biological replicates for tonsils, intestine and cervix. Percentages in ART were subtracted from those in each LRA-stimulated condition. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted. b Pie charts illustrating the contribution of LRAs to HIV reactivation in tonsillar and intestinal CD4+ T cells. N = 9 and 7 biological replicates for tonsils and intestine. Means are depicted. Statistical comparisons between tissues were performed. c SIMOA measurements of p24 in supernatants from tonsillar and intestinal CD4⁺ T cells HIV-infected (HIV+), ART-treated and ART-treated LRA-stimulated. N = 3 biological replicates per tissue. d Effect of LRAs on ART-treated tonsillar and intestinal CD4+ T-cell subpopulations. Graphs display the percentage of p24+ cells within clusters following stimulation with ING, I+R, AZD or IL-15. Percentages in ART were subtracted. N = 9 biological replicates per tissue. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted. e Pie charts illustrating the contribution of each cluster to total reactivated CD4+ T cells from tonsillar and intestinal tissues. Percentages were calculated as the proportion of p24⁺ cells in each cluster relative to total p24⁺ CD4⁺ T cells. N = 9 biological replicates per tissue. Median percentages are depicted, and statistical comparisons between tissues were conducted. Smaller pie charts represent the median percentage of each cluster within the LRA-stimulated CD4+ T-cell population. Statistical tests (all two-sided): Wilcoxon test (a, d); Mann-Whitney (b, e). Significance levels are indicated numerically or as *p < 0.05; **p < 0.01; ***p < 0.001. All experiments except (c) were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 6 Heterogeneous responses of tonsillar and intestinal CD4+ T-cell subpopulations to LRAs. Viral reactivation with LRAs in the ART-treated CD4+ T-cell clusters from tonsillar and intestinal tissues: a C03:TCM, b C06:TTEM CD69+, c C08:TFH CD69+ CCR7+, d C09:TFH CD69+ CCR7-, e C10:TRM CD69+ PD-1+, f C11:TRM CD69+ CD49a+, and g C12:TRM CD69+ CD49a+ CD103+. Graphs displaying the percentage of p24+ cells within the CD4+ T-cell subpopulations in unstimulated (ART) and LRA-stimulated conditions: PMA and ionomycin (PMA+Iono), Ingenol (ING), Romidepsin (RMD), Ingenol and Romidepsin (I+R), Panobinostat (PNB), AZD5582 (AZD) and IL-15. Percentages of p24+ cells in ART were subtracted from those in each LRA-stimulated condition. N = 9 biological replicates per tissue. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted using the two-sided Wilcoxon test, with significance levels indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.
Fig. 6 Heterogeneous responses of tonsillar and intestinal CD4+ T-cell subpopulations to LRAs. Viral reactivation with LRAs in the ART-treated CD4+ T-cell clusters from tonsillar and intestinal tissues: a C03:TCM, b C06:TTEM CD69+, c C08:TFH CD69+ CCR7+, d C09:TFH CD69+ CCR7-, e C10:TRM CD69+ PD-1+, f C11:TRM CD69+ CD49a+, and g C12:TRM CD69+ CD49a+ CD103+. Graphs displaying the percentage of p24+ cells within the CD4+ T-cell subpopulations in unstimulated (ART) and LRA-stimulated conditions: PMA and ionomycin (PMA+Iono), Ingenol (ING), Romidepsin (RMD), Ingenol and Romidepsin (I+R), Panobinostat (PNB), AZD5582 (AZD) and IL-15. Percentages of p24+ cells in ART were subtracted from those in each LRA-stimulated condition. N = 9 biological replicates per tissue. Medians with quartiles are represented. Statistical comparisons between unstimulated and LRA-reactivated conditions were conducted using the two-sided Wilcoxon test, with significance levels indicated numerically. All experiments were independently replicated, each run including tissue samples from distinct donors. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central
Fig. 7 HIV-reactivation of sorted CD4+ T-cell subpopulations from tonsillar and intestinal tissues. Percentage of p24+ cells in sorted (a) tonsillar (TO) TNA (CD45RO⁻ CCR7⁺ CD69⁻) and TFH (CXCR5⁺ PD-1⁺) subpopulations and (b) intestinal (GUT) TRM (CD45RO⁺ CCR7⁻ CD69⁺ CXCR5⁻) and TNON-RM (CD69⁻) CD4⁺ T cells unstimulated (ART) and following stimulation with PMA and ionomycin (PMA+Iono), the combination of Ingenol and Romidepsin (I+R) and IL-15. Ingenol (ING) was also used for tonsillar cells. Percentages of p24+ cells in ART were subtracted from those in each LRA-stimulated condition. Means with standard error of means (SEM) are represented. c Effect of LRA stimulation on the expression of phenotypic markers in sorted CD4⁺ T-cell populations from tonsillar and intestinal tissues. Histograms represent the Mean Fluorescence Intensity (MFI) of each marker across conditions within the CD4+ T-cell subpopulations. N = 1 and 2 biological replicate for tonsils and intestine, respectively. Experiments with intestinal samples were duplicated in independent runs, each run including one tissue sample from a distinct donor. Source data are provided as a Source Data file.
Fig. 7 HIV-reactivation of sorted CD4+ T-cell subpopulations from tonsillar and intestinal tissues. Percentage of p24+ cells in sorted (a) tonsillar (TO) TNA (CD45RO⁻ CCR7⁺ CD69⁻) and TFH (CXCR5⁺ PD-1⁺) subpopulations and (b) intestinal (GUT) TRM (CD45RO⁺ CCR7⁻ CD69⁺ CXCR5⁻) and TNON-RM (CD69⁻) CD4⁺ T cells unstimulated (ART) and following stimulation with PMA and ionomycin (PMA+Iono), the combination of Ingenol and Romidepsin (I+R) and IL-15. Ingenol (ING) was also used for tonsillar cells. Percentages of p24+ cells in ART were subtracted from those in each LRA-stimulated condition. Means with standard error of means (SEM) are represented. c Effect of LRA stimulation on the expression of phenotypic markers in sorted CD4⁺ T-cell populations from tonsillar and intestinal tissues. Histograms represent the Mean Fluorescence Intensity (MFI) of each marker across conditions within the CD4+ T-cell subpopulations. N = 1 and 2 biological replicate for tonsils and intestine, respectively. Experiments with intestinal samples were duplicated in independent runs, each run including one tissue sample from a distinct donor. Source data are provided as a Source Data file.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 139 references

Cited by

See all 22

Metadata

Authors
Gallego-Cortés, A., Sánchez-Gaona, N., Mancebo-Pérez, C., Ruiz-Isant, O., Benítez-Martínez, A., Landolfi, S., Castellví, J., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Mañalich-Barrachina, L., Prado, J., Martín-Gayo, E., Falcó, V., Genescà, M., & Buzon, M.
Affiliations
  • Universitat Autònoma de Barcelona (ES)
  • Vall d'Hebron Hospital Universitari (ES)
Venue
Nature Communications
Published
2025-11-24
Volume
16
Issue
1
Pages
10353-10353
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4416690738
Cited by
12
References
139
Citations by year
2026: 12
FWCI
6.01
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • "la Caixa" Foundation (LCF/PR/HR20/00218)
  • Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (CPII22/00005, PI20/00160)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords
HIV reservoir, HIV latency, tonsillar tissue, intestinal tissue, tissue models, CD4+ T cell subsets, tissue-resident memory T cells, T follicular helper cells, CD69, CD45RO, PD-1, CXCR5, CD49a, latency reversal agents, histone deacetylase inhibitors, IL-15, HIV cure
MeSH terms
Cervix Uteri, Disease Reservoirs, Female, Humans, Intestinal Mucosa, Intestines, Palatine Tonsil, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, Antigens, CD, Virus Latency

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency. https://app.cochat.ai/papers/10.1038/s41467-025-65288-9
The paper
Gallego-Cortés, A., Sánchez-Gaona, N., Mancebo-Pérez, C., Ruiz-Isant, O., Benítez-Martínez, A., Landolfi, S., Castellví, J., Pumarola, F., Ortiz, N., Llano, I., Lorente, J., Mañalich-Barrachina, L., Prado, J., Martín-Gayo, E., Falcó, V., Genescà, M., & Buzon, M. (2025). Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency. Nature Communications. https://doi.org/10.1038/s41467-025-65288-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.